New approaches for improving engraftment after cord blood transplantation.
about
Counteracting the enzymatic activity of dipeptidylpeptidase 4 for potential therapeutic advantage, with an emphasis on cord blood transplantationProspective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies.Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemiaEngineering cord blood to improve engraftment after cord blood transplant.Modelling the sitagliptin effect on dipeptidyl peptidase-4 activity in adults with haematological malignancies after umbilical cord blood haematopoietic cell transplantation.Hematopoietic, CNS and skeletal muscle stem cells as drug targets: opportunities, progress and challenges.Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models.Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysisSerious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulinPleiotropic effects of prostaglandin E2 in hematopoiesis; prostaglandin E2 and other eicosanoids regulate hematopoietic stem and progenitor cell function.Cationic liposome-mediated CXCR4 gene delivery into hematopoietic stem/progenitor cells: implications for clinical transplantation and gene therapy.The role of complement in the trafficking of hematopoietic stem/progenitor cells.Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function.Insights and hopes in umbilical cord blood stem cell transplantationsA soluble granulocyte colony stimulating factor decoy receptor as a novel tool to increase hematopoietic cell homing and reconstitution in mice.In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignanciesCytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning.Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) and Société FrançaComparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia.Hematopoietic stem cell homing to injured tissues.Insights into the biology of cord blood stem/progenitor cells.Ex vivo expansion of umbilical cord blood: where are we?Umbilical cord blood graft enhancement strategies: has the time come to move these into the clinic?Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation.Improving engraftment and immune reconstitution in umbilical cord blood transplantation.Aging Effects on Cardiac Progenitor Cell Physiology.Bcl-2 proteins in development, health, and disease of the hematopoietic system.Human Umbilical Cord Blood Cell Transplantation in Neuroregenerative StrategiesMiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantationEx vivo rapamycin treatment of human cord blood CD34+ cells enhances their engraftment of NSG miceHaematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf.The impact of CD34+ cell dose on engraftment after SCTs: personalized estimates based on mathematical modeling.Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of ETransient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation.Bone marrow CD34+ cells expanded on human brain endothelial cells reconstitute lethally irradiated baboons in a variable manner.Effect of maternal iron status on the number of CD34+ stem cells harvested from umbilical cord blood.Predicting the quality of transplantable cord blood collections through prefreeze and postthaw Apgar scoring.
P2860
Q27012935-3FCD2787-0155-44B6-8252-5D1C54BCA8D9Q30423085-92906C8E-F4A1-483C-B0AF-51F25AC2844AQ33392788-A245AB2A-540C-4110-96E2-523938ED13A0Q33766995-14A20674-5A79-44E9-AE0F-E5344564EB05Q34046207-9FB0D256-6C7D-4559-8CDE-D6A5A2AC0ECFQ34212796-4CAAB049-5C00-4B08-8ADE-B8FED665C189Q35001593-DD2AF061-613F-48CE-B357-E7917E6AB153Q35140717-C95F43D3-90A4-468E-8946-7BE48FE31456Q35185685-8DB71D1B-82F1-440A-94AE-4E97D2788934Q35190671-082C52A1-81E0-4D4E-8290-49F669B5A30DQ35501630-69605A11-4726-4A19-A02F-98EB1B08EEC1Q36036499-DD908CF4-B330-45D4-8FED-C4C16908EF25Q36110279-697BD8F3-B95F-4B95-B2A7-74CEB1E13CCAQ36192813-F9F3A710-2B41-4320-ADC8-4A65F6386FDEQ36432837-3D2CF2CC-64DD-4704-B04D-BD6DBC914321Q36648047-4D7FBC8C-35F9-41B0-9768-D0DAD2E89BA8Q36715531-DBCAFDBF-6A3B-4264-9031-9D6F1D0F0B7BQ36743361-2EF3997B-31DC-4E62-B8DB-41D0809EC9B2Q36962694-3B75CF78-C5B8-4AA6-9C1A-F01CDF9A304DQ36967170-DDA123DA-A281-42F7-9D42-2B138A9EE3E8Q37472615-096B04F0-12DD-4F45-BE82-0DE13B7BDD7CQ37845721-6A9FB29C-7E42-4293-9C2A-C451BECBA0C4Q37863720-7F0D406B-6C52-4AD0-A27B-83DCF164593DQ37995979-26FFD5FD-E832-4324-A368-7E9388DDCF84Q38039945-108E352B-9262-4A34-AAB5-57BB33F572C4Q38105635-CF1A3A66-5E11-4B50-AED4-FB588AD9CA13Q38194133-6C8C7DB7-9214-4CFC-9653-1FD282CA8ADFQ38596695-896B41AB-889C-4067-9CF9-D960E228F7F4Q38735628-B0BE801B-DA24-4954-9E3F-7EF43917242FQ41688586-BE1B78DC-E35E-4DE8-A653-6B43F13462FCQ42069315-C496D6E3-0E3D-4369-A807-9680917B868CQ42715456-24BE6131-CD0B-46C9-9957-049B834A0670Q43186413-843C2D88-114C-45DF-8EA1-F238F9DF17DAQ43417842-E3BFC073-60F2-4CB0-AA8E-9426C7E0D4F7Q46788345-9CDCF630-A7FB-4CEE-ACA7-0CF2DC96EFC6Q47838233-3FF2C5CA-DFA1-4C55-A5E4-A93EEBE40607Q48198646-78C7BD8E-E129-453B-9B44-04B401858E3DQ50475892-1C3A2501-1718-47D5-8062-D92945171571Q51640323-D74E7B1F-C9CE-4701-9781-345E14013D45
P2860
New approaches for improving engraftment after cord blood transplantation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
New approaches for improving engraftment after cord blood transplantation.
@en
New approaches for improving engraftment after cord blood transplantation.
@nl
type
label
New approaches for improving engraftment after cord blood transplantation.
@en
New approaches for improving engraftment after cord blood transplantation.
@nl
prefLabel
New approaches for improving engraftment after cord blood transplantation.
@en
New approaches for improving engraftment after cord blood transplantation.
@nl
P1476
New approaches for improving engraftment after cord blood transplantation.
@en
P2093
Hal E Broxmeyer
Vanderson Rocha
P304
P356
10.1016/J.BBMT.2009.11.001
P433
P577
2009-11-05T00:00:00Z